44th week of 2009 patent applcation highlights part 45 |
Patent application number | Title | Published |
20090270238 | CENTRIFUGE, IN PARTICULAR SEPARATOR, HAVING A FEED LINE FOR CONTROL FLUID - A separator includes a rotatable centrifugal drum having a vertical axis of rotation. The separator includes a rotatable drive spindle to drive the drum, an hydraulic system located in an interior of the drum and at least one feed line to feed a control fluid to the drum, the at least one feed line having an outlet region. Further included is a ring non-rotatably connected to the drum, a gap located between one of the drive spindle and the drum and the drive spindle and the ring. The feed line leads out radially in front of the drive spindle in the outlet region. The outlet region is oriented and configured such that emerging control fluid is spread directly against the drive spindle, and a portion of the control fluid enters through the gap into the hydraulic system. | 2009-10-29 |
20090270239 | Black Complex Oxide Particles, Process for Producing the Same, Black Pastes, and Black Matrixes - The complex oxide particles of the present invention have a black hue, and contains 35 to 70% by weight of cobalt and 5 to 40% by weight of manganese. The molar ratio of cobalt to manganese Co/Mn is 0.5 to 14. The average particle diameter of primary particles is 0.05 to 0.3 μm. The particles have a shape of octahedral form. The particles are produced preferably through wet oxidation. No firing process is performed. The particles contain substantially no metal elements other than cobalt and manganese. The complex oxide particles of the present invention are suitably used as a black pigment for coating material, ink, toner, and rubbers or plastics. | 2009-10-29 |
20090270240 | COVER COATING COMPOSITION FOR GLASS LINING - Provided is a cover coating composition for a glass lining comprising a frit constituting the composition which mainly includes 65 to 75 mol % of SiO | 2009-10-29 |
20090270241 | Ga-P-S glass compositions - Ga—P—S glass compositions that may have application in infrared (IR) windows, waveguiding fibers, or as host glasses for luminescent dopants are described. | 2009-10-29 |
20090270242 | Alkali-free glass and alkali-free glass substrate - An alkali-free glass characterized by having a glass composition being substantially free of an alkali metal oxide, As | 2009-10-29 |
20090270243 | TITANIUM-CONTAINING ADDITIVE - A titanium-containing additive, a method for its production and methods of using the additive. | 2009-10-29 |
20090270244 | Low-Loss Microwave Dielectric Ceramic - There is provided a low-loss microwave dielectric ceramic having a composition represented by xCaO.yLn | 2009-10-29 |
20090270245 | CATALYTIC MATERIALS AND METHOD FOR THE PREPARATION THEREOF - The invention is related to catalytic materials and particularly to mesoporous molecular sieves embedded with a zeolite, which are thermally stable at a temperature of at least 900° C., and to a method for the preparation of the catalytic materials. Said catalytic materials are suitable for applications in the field of hydrocarbon processing. | 2009-10-29 |
20090270246 | Structured bodies with siliceous binder - The invention relates to the use of particulate silicone resins in the absence of added organic solvents with particulate inorganic materials to form structured bodies and in particular molecular sieve containing structured bodies. The silicone resin is used in the form of a particulate with an average particle size of less than 700 um. Upon calcining, the silicone resin is converted to silica which acts as a binder. | 2009-10-29 |
20090270247 | IN SITU OLEFIN POLYMERIZATION CATALYST SYSTEM - Embodiments in accordance with the present invention encompass methods of forming in situ olefin polymerization catalyst systems, catalysts encompassed by such systems and polymers made using such systems. For such in situ olefin polymerization catalyst systems, a hydrocarbyl magnesium halide is generally contacted with a halohydrocarbyl compound to form a halohydrocarbyl Grignard and such Grignard is generally contacted with a Group 10 metal compound to form an olefin polymerization catalyst which is contacted with one or more olefin monomers to form a polymer therefrom. | 2009-10-29 |
20090270248 | Basic ionic liquids - Use of ionic liquids as solvents in base-catalysed chemical reactions wherein the ionic liquid is composed of at least one species of cation and at least one species of anion, characterised in that a cation of the ionic liquid comprises a positively charge moiety and a basic moiety, and further wherein such ionic liquids may be used as promoters or catalysts for the chemical reactions. | 2009-10-29 |
20090270249 | METHOD FOR FORMING A CATALYST CARRIER - A method of forming a carrier material suited to use in Fischer-Tropsch reactions includes forming a dispersion of first and second hydrated alumina materials in a liquid dispersant, such as an acid solution. The first alumina can be derived from an alkali aluminate, such as is formed in the Bayer reaction. The second hydrated alumina can be derived from high purity aluminum, such as via conversion to an alkoxide. The dispersion is spray dried to form particles which are heat treated to form a carrier material having low levels of impurities. | 2009-10-29 |
20090270250 | PRODUCTION METHOD OF OXIDATION CATALYST DEVICE FOR EXHAUST GAS PURIFICATION - According to a first embodiment of a production method of an oxidation catalyst device for exhaust gas purification of the present invention, a plurality of slurries containing a catalyst precursor prepared from mutually different organic acids is coated respectively on a porous filter carrier ( | 2009-10-29 |
20090270251 | Cobalt compositions and methods of making the same - The present invention is directed to cobalt compounds and methods for making such metal oxide compositions, specifically, metal oxide compositions having high surface area, high metal/metal oxide content, and/or thermal stability with inexpensive and easy to handle materials. | 2009-10-29 |
20090270252 | ACID RESISTANT CERAMIC MATERIALS, FILTER USING THE SAME, AND PREPARATION OF THEM - The present invention provides porous ceramic materials having good resistance to heat, acid and base, comprising three or more oxides selected from an oxide of silicon (SiO), an oxide of aluminum (AlO), an oxide of a transition metal, MxOy, [wherein M represents a 4B, 5B or 6B-group transition metal which can be selected from Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W or Ce, x represents an integer of 1 to 3, and y represents an integer of 1 to 3] and its preparation. By applying ceramic materials prepared according to the present invention that are structurally, thermally and chemically stable to a porous honeycomb support for the purification of exhaust gas or to a filter (DPF, Diesel Particulate Filter) for the purification of diesel engine exhaust gas, it is possible to prevent or remarkably reduce any structural destruction caused by corrosive gas, which results from employing a cordierite material as a structural support. | 2009-10-29 |
20090270253 | Composite metal oxide adsorbent for fluoride removal - The invention provides a composite metal oxide adsorbent for fluoride removal and the preparation method thereof. Said composite metal oxide adsorbent for fluoride removal comprises: 0.05-0.15 molar parts of transition metal, 0.2-0.6 molar parts of Al and/or Mg, and 0.05-0.15 molar parts of rare earth metal. The composite metal oxide adsorbent for fluoride removal has a saturation adsorption capacity on fluorine in water of up to 229 mg/g, under a neutral condition. | 2009-10-29 |
20090270254 | Increase of stress tolerance by application of neonicotinoids on plants engineered to be stress tolerant - The present invention relates to methods for increasing the stress tolerance in plants and plant cells whereby neonicotinoid compounds, such as but not limited to imidacloprid, clothianidin, thiamethoxam, dinotefuran, nitenpyram, acetamiprid or thiacloprid, are applied to plants, or cells thereof, which comprise a genome that has been modified to make the plants or their cells more stress tolerant i.e. plants engineered to be stress tolerant. Particularly effective stress tolerance synergists in combination with genetically modified stress tolerant plants or their cells are neonicotinoid compounds which comprise a chloropyridine side chain, like e.g. imidacloprid, thiacloprid, acetamiprid, nitenpyram and 6-chloronicotinic acid (6-CNA). | 2009-10-29 |
20090270255 | Triazole-Based fungicidal Mixtures - Fungicidal mixtures, comprising
| 2009-10-29 |
20090270256 | Azolylmethyloxiranes, Use Thereof for Controlling Plant Pathogenic Fungi, and Agents Containing the Same - The present invention relates to azolylmethyloxiranes of the general formula I | 2009-10-29 |
20090270257 | Controlled release fertilizers containing calcium sulfate and processes for making same - An extended release fertilizer that includes an absorbent material containing capillaries/voids between 10-200 microns in cross-sectional diameter which is impregnated in an amount of 40-95% of the capillaries/voids volume with an agriculturally beneficial material, or alternatively includes a holding agent retaining an agriculturally beneficial material, wherein the beneficial material at least includes calcium sulfate, and the beneficial material is selected from the group consisting of fertilizers, insecticides, herbicides and fungicides, with the resulting material being agglomerated into granules. | 2009-10-29 |
20090270258 | Pesticide and/or herbicide compositions and methods of their use - A pesticide or herbicide composition that is either a sprayable formulation or an aqueous concentrate which is dilutable to form a sprayable formulation comprising, water containing therein, i) at least one pesticide or herbicide active and ii) a spray drift control agent comprising at least one water-soluble cationic polymer that has been formed from ethylenically unsaturated monomers and iii) at least one cationic surfactant. The composition can be used to treat a crop area or an area of land. | 2009-10-29 |
20090270259 | Novel Agrochemical Formulations - The present invention comprises methods for producing a formulation with controlled active substance release, wherein a Pickering emulsion of the solvent in water type is applied to a solid carrier, and also formulations with controlled active substance release producible by the abovementioned method. | 2009-10-29 |
20090270260 | RE123-Based Oxide Superconductor and Method of Production of Same - An RE123-based oxide superconductor characterized by comprising a conductive layer containing an REBa | 2009-10-29 |
20090270261 | Superconducting Device for Current Conditioning - The device has a quenchable superconductor ( | 2009-10-29 |
20090270262 | MAGNETOELECTRIC SUSCEPTIBILITY MEASUREMENT METHOD AND THE SYSTEM THEREOF - Disclosed herein is a method and system for measuring magnetoelectric susceptibility. The system includes a magnet supplying a DC magnetic bias to a magnetoelectric sample, an AC drive coil applying an AC magnetic field to the magnetoelectric sample, a charge amplifier amplifying an electric charge signal of the magnetoelectric sample oscillating by the AC magnetic field, and a phase sensitive detector detecting the voltage signal produced by the charge amplifier while supplying induction current to the AC drive coil. Accordingly, it is possible to provide a highly sensitive system for measuring magnetoelectric susceptibility, which is essential for research on multiferroic and magnetoelectric bulk and thin film materials at room temperature, and can also operate in the physical property measurement system (PPMS, manufactured by Quantum Design Co., Ltd.) for measurements under low temperature and high magnetic field environments. | 2009-10-29 |
20090270263 | PROCESS FOR PRODUCING TAPE-SHAPED Re-TYPE (123) SUPERCONDUCTOR - This invention provides a production process of a tape-shaped superconductor which can realize high Jc and Ic values by virtue of the elimination of the cause of generation of cracks and deterioration of an electrical connectivity in crystal grain boundaries. In producing an Re-base (123) superconductor on a substrate by an MAD process, the use of a raw material solution having a Re:Ba:Cu molar ratio of 1:X:3, wherein X is a Ba molar ratio satisfying X<2 (preferably 1.0≦X≦1.8, especially 1.3≦x≦1.7), can realize the production of a thick-film tape-shaped superconductor having a superconductivity of Jc=3.20 MA/cm2 and Ic=525 A/cm (X=1.5). | 2009-10-29 |
20090270264 | SYSTEM AND METHOD FOR THE DECONVOLUTION OF MIXED DNA PROFILES USING A PROPORTIONATELY SHARED ALLELE APPROACH - A total forensic DNA casework management system and method for the deconvolution of mixed DNA samples using a novel, 3-rule algorithm to determine the proportional allele sharing of the sample's contributors. The process is fully document, can assess and process DNA anomalies and artifacts, and transforms raw STR data to produce final DNA profile types, peak height ratios, proportions, fitting criteria and associated graphs. | 2009-10-29 |
20090270265 | Molecular Characteristics of Non-Small Cell Lung Cancer - We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation. The messages of two p53-regulated genes, p21 | 2009-10-29 |
20090270266 | Method for Electrocatalytic Protein Detection - The present invention provides a method of detecting an analyte in a sample with probe-modified electrodes and measuring an electrocatalytic signal generated by a binding of an analyte in the sample to a probe. | 2009-10-29 |
20090270267 | Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer - This invention relates to a composition, kit, or DNA chip comprising polynucleotides and antibodies as probes for detecting, determining, or predicting the presence or metastasis of esophageal cancer, and to a method for detecting, determining, or predicting the presence or metastasis of esophageal cancer using the same. | 2009-10-29 |
20090270268 | Methods for Obtaining Immortalized Antibody Secreting Cells - The present Invention provides novel methods for immortalizing cells that secrete antibodies of one or more specific isotypes. Polyclonal, oligoclonal, and monoclonal populations of cells obtained using the methods of the Invention can be screened on the basis of the functional and/or binding activities of the antibodies they secrete, for example directed to antigens of human or viral origin having medical interest, in cell culture conditions. Using these methods, human B cells that secrete antibodies binding human Cytomegalovirus, Herpes Simplex Virus, or HSP60 protein have been efficiently immortalized with Epstein-Barr virus. | 2009-10-29 |
20090270269 | NANO-SCALE FLUORO-BIOSENSORS EXHIBITING A LOW FALSE ALARM RATE FOR RAPID DETECTION OF BIOLOGICAL CONTAMINANTS - A sensing system incorporating a nano-scale fluoro-biosensor for detection of specifically targeted bio-contaminants (targets). Select embodiments use fluorescent nanoparticles such as quantum dots (QD) conjugated to antibody fragments to form a sensor for a specific bio-contaminant based on fluorescent resonance energy transfer (FRET). A quenching dye may be used to label an analog, while a specific antibody is covalently bonded to a hydrophilic QD. Coupling of QD labeled antibodies and quencher labeled analogs provides enough proximity to produce appreciable FRET-based quenching. Any addition of the target displaces the dye-labeled bacteria, eliminating FRET-based quenching and results in a concentration-dependent increase in QD photoluminescence. Applications include rapid detection and identification, with a high degree of specificity and sensitivity, of a broad range of targets, including viral contaminants, e.g., in less than about three minutes. By using QDs of varying wavelengths the system may be adapted into a multiplexing immuno-assay. | 2009-10-29 |
20090270270 | METHOD FOR DETECTING INTRAGENIC LARGE REARRANGEMENTS - The invention relates to methods for detecting at least one intragenic large rearrangement in a gene of interest, mapping the rearrangement breakpoint and diagnosing a genetic disease in a subject. | 2009-10-29 |
20090270271 | 3' Biased Detection of Nucleic Acids - The invention provides materials and methods for the detection of nucleic acid expression via the 3′ portion of expressed sequences. Embodiments of the invention include the use of microarrays comprising nucleic acid probes that are complementary to the 3′ end of expressed sequences and by the use of quantitative PCR (Q-PCR) based amplification of sequences found at or near the 3′ end of expressed sequences. The invention may be used to detect the presence of expressed nucleic acids encoding particular gene products (sequences present in a “transcriptome”). | 2009-10-29 |
20090270272 | ASSESSING RISK OF DISEASE PROGRESSION IN RHEUMATOID ARTHRITIS PATIENTS - Disclosed is an in vitro method aiding in the further assessment of patients suffering from rheumatoid arthritis. The method especially is used in assessing whether an RA patient is at risk of disease progression. The method is for example practiced by analyzing biochemical markers, comprising measuring in a sample the concentration of at least C-reactive protein (CRP) and interleukin-6 and correlating the concentrations determined to the likelihood of an underlying rapidly progressing form of RA. A patient at high risk of a rapidly progressing disease might be a patient in need for treatment or if already treated in need for a different and more effective treatment. The invention also relates to the use of a marker panel comprising C-reactive protein and interleukin-6 in the assessment of a patient with rheumatoid arthritis and it teaches a protein array device and kit, respectively, for performing the method of the invention. | 2009-10-29 |
20090270273 | ARRAY STRUCTURES FOR NUCLEIC ACID DETECTION - Devices formed as optically readable substrates are provided having a high feature density (e.g., attachment or deposition sites) in arrays comprising macromolecules, specifically amplicons, and devices and methods are provided for analysis of target nucleic acids having an undetermined sequence. High density arrayed nucleic acids are provided which are amenable to individual or multiple nucleotide interrogation, and which are particularly useful to determine the nucleotide sequence of a complex target nucleic acid sequence | 2009-10-29 |
20090270274 | BIOCHIPS AND RELATED AUTOMATED ANALYZERS AND METHODS - The present invention provides biochips that include: (a) a plurality of cards, each card having a plurality of card apertures extending therethrough, each respective card aperture having one or more cross sectional areas; and (b) a plurality of gaskets, at least one gasket residing intermediate two neighboring cards, each gasket having a plurality of gasket apertures extending therethrough. At least some of the gasket apertures have an area that is greater than that of at least one adjacent card aperture. Different sets of the gasket apertures and card apertures define a plurality of fluidic flow channels. Also provided herein are methods of making and using biochips. | 2009-10-29 |
20090270275 | METHOD AND APPARATUS FOR SCANNING BIO CHIPS USING LIGHT AMPLICATION BY METAL NANO-PARTICLES - The present invention utilizes a principle in which, in a state in which metal nano-particles are attached to target probes and used as markers, and the metal nano-particles have a proper density according to a bio reaction between the target probes and fixed probes, when the metal nano-particles are irradiated with a laser beam having a proper intensity from the optical pick-up head, a higher optical energy is delivered to the phase change layer by an optical amplification effect caused by the metal nano-particles, thereby better inducing an amorphous-to-crystalline phase change. | 2009-10-29 |
20090270276 | BEAD IMMOBILISATION METHOD AND BEAD ARRAYS MADE THEREBY - A bead immobilization method including receiving at least one bead in at least one well in a casting surface, and casting a casting material over the casting surface to form a reverse casting in which the at least one bead is cast onto at least one post upstanding from a surface of the reverse casting. | 2009-10-29 |
20090270277 | METHOD FOR INDEXING NUCLEIC ACID SEQUENCES FOR COMPUTER BASED SEARCHING - The present invention relates to a method for indexing nucleic acid sequences to aid computer based searching of nucleic acid sequences by indexing a nucleotide sequence by the presence of unique Kmers in the sequence. The method of the present invention comprises utilizing an algorithm to automatically index a nucleic acid sequence. | 2009-10-29 |
20090270278 | Methods and compounds for making arrays - Arrays and methods of making an array are described. A plurality of beads, each bead comprising a group of compounds, each compound of said group attached to a bead through a photocleavable linker are brought in proximity (or contact) with another surface, and exposed to electromagnetic radiation. Illuminating the beads with radiation causes at least a portion of the compounds to be photocleaved from the beads and transferred to the surface to form a plurality of transferred groups of compounds on said surface, at least a portion of which is positioned in different locations on said surface. | 2009-10-29 |
20090270279 | Materials and Methods for the Photodirected Synthesis of Oligonucleotide Arrays - Materials and Methods for photodirected synthesis of oligonucleotide arrays on a solid substrate by photodirected synthesis are disclosed which employ a film formed from (i) a photoacid generator that on photolysis generates acid that is capable of directly removing the protecting group of the linker molecules or oligonucleotides and (ii) a polymer substantially lacking electronegative heteroatoms that are capable of hydrogen bonding with photogenerated acid. Methods of synthesizing an oligomer arrays are also described that use a film that restricts diffusion of reactants and products on the substrate during synthesis of the array and which includes a precursor of a deprotecting reagent. The method involves removing one or more of the non-required products of the deprotection reaction from the reactive array elements at which they are produced during the reaction, in order to displace the deprotection reaction towards completion. | 2009-10-29 |
20090270280 | Water-in-Oil Emulsions With Hydrogel Droplets Background - Methods and compositions are provided that include a water-in-oil composition comprising an oil-based continuous phase and a discontinuous phase that comprises at least a plurality of hydrogel droplets and a method comprising providing a water-in-oil emulsion comprising an oil-based continuous phase and a discontinuous phase that comprises at least a plurality of hydrogel droplets; and placing the water-in-oil emulsion in a well bore penetrating a subterranean formation. Additional methods are also provided. | 2009-10-29 |
20090270281 | USE OF SURFACTANT MIXTURES FOR TERTIARY MINERAL OIL EXTRACTION - The use of a surfactant mixture comprising at least one surfactant having a hydrocarbon radical composed of from 12 to 30 carbon atoms and at least one cosurfactant having a branched hydrocarbon radical composed of from 6 to 11 carbon atoms for tertiary mineral oil extraction. | 2009-10-29 |
20090270282 | PROCESS OF HYDRAULIC FRACTURING - Hydraulic fracturing of a subterranean hydrocarbon reservoir is carried out using an aqueous wellbore fluid which is an aqueous solution of a surfactant which has the formula(R | 2009-10-29 |
20090270283 | Process for Deposition of Amorphous Carbon - There is a coated, dynamic contact surface. The contact has a substrate and a carbon-based coating on the substrate. The coating has a coefficient of friction of about 0.5 or less and an atomic hydrogen content of about 5% to about 25%. There is also a mechanical system. There is a method for increasing oil-out survivability in a mechanical system. | 2009-10-29 |
20090270284 | FRICTION MODIFIER, METHOD OF PRODUCING FRICTION MODIFIER, AND FRICTION MATERIAL - A friction modifier is provided with a titania particle-layered clay mineral complex in which titania particles are contained in a layered clay mineral. An average particle diameter of the titania particles is 3 to 100 nm. A ratio of the titania particles to the titania particle-layered clay mineral complex is 0.1 to 0.8 on the mass basis. | 2009-10-29 |
20090270285 | Star Polymer Lubricating Composition - The invention provides a lubricating composition containing (a) a polymer derived from greater than 50 wt % or more of a non-diene monomer, wherein the polymer has a weight average molecular weight of about 2000 to about 200,000, and wherein the polymer has a shear stability index of about 0 to about 25; (b) a phosphorus-containing acid, salt, or ester; (c) an extreme pressure agent, other than a phosphorus-containing acid, salt, or ester; and (d) an oil of lubricating viscosity. The invention further provides a method for lubricating a mechanical device with the lubricating composition. | 2009-10-29 |
20090270286 | Synthetic Lubricating Oil - The object of the present invention is to provide a synthetic lubrication oil which shows low viscosity, is excellent in viscosity properties at high temperature and shows stable lubricating properties in a wide range of temperature. The synthetic lubricating oil is one comprising an ionic liquid containing an organic cation selected from the group consisting of an imidazolium cation, a pyridinium cation, a quaternary ammonium cation and a quaternary phosphonium cation and a bis(fluorosulfonyl)imide anion, and one comprising an ionic liquid composition which comprises an ionic liquid (A) containing a 1-ethyl-3-methylimidazolium cation and an ionic liquid (B1) containing a 1-methyl-3-propylimidazolium cation and/or an ionic liquid (B2) containing a 1-methyl-3-isopropylimidazolium cation. | 2009-10-29 |
20090270287 | OIL COMPOSITION FOR LUBRICATING AN EGR EQUIPPED DIESEL ENGINE AND AN EGR EQUIPPED DIESEL ENGINE COMPRISING SAME - The present invention is directed to a lubricating oil composition, a diesel engine comprising a lubricating oil composition, and a method of lubricating a diesel engine provided with an exhaust gas recirculation system, comprising lubricating said engine with a lubricating oil composition comprising an oil of lubricating viscosity, and a polymeric N-dispersant booster comprising monomer units of:
| 2009-10-29 |
20090270288 | ALKYL ACETAL COMPOUND, PROCESS FOR PRODUCING THE SAME, AND LUBRICATING OIL COMPOSITION - A compound which satisfies requirements for the annealing property and the lubricating property simultaneously and a process for producing the compound are provided. The compound is an alkylacetal compound represented by the following general formula (1) or (2). In the general formulae, R | 2009-10-29 |
20090270289 | Phosphorus-molybdenum compound, method for producing same and lubricant additive and lubricant composition containing the compound - A lubricating oil additive capable of providing an antioxidant which enables a lubricating oil composition to have long drain intervals, while reducing specific components such as metals and phosphorus atoms, and a lubricating oil composition containing the lubricating oil additive are provided. A phosphorus molybdenum compound represented by the following general formula (1) | 2009-10-29 |
20090270290 | Grease composition - A grease composition, which comprises a base oil selected from at least one of synthetic hydrocarbon oil, ester-based synthetic oil, and ether-based synthetic oil; a thickening agent selected from at least one of lithium-based soap, lithium-based complex soap, and a urea-based compound; polytetrafluoroethylene resin powders having a number average molecular weight Mn of 20,000-100,000; and zinc dialkyldithiophosphate having straight or branched alkyl groups of at least carbon atoms, preferably 5-13 carbon atoms, and more preferably 8-12 carbon atoms, has not only a distinguished lubricability, when applied to plastic members, but also a distinguished durability as given by change in friction coefficient and wear loss, after the sliding test. | 2009-10-29 |
20090270291 | Wet Lubricant Surface Coating Having Excellent Durability, Method for Surface Coating, and a Medical Device Having The Surface Coating - A lubricant surface coating having good lubricity and high durability, comprising (A) an urethane polymer layer comprising (a) 40 to 80% by weight of at least one component selected from an aromatic diisocyanate, an aliphatic diisocyanate and an alicyclic diisocyanate and (b) 20 to 60% by weight of a polyol having at least trifunctionality and (B) a hydrophilic polymer layer provided as the outer layer for the urethane polymer layer which comprises a polyalkylene glycol and/or a monomethoxypolyalkylene glycol; and a medical device having the surface coating. | 2009-10-29 |
20090270292 | Lubricant Composition - A lubricant composition, which comprises a fluoro-oil, a powdery fluororesin thickener, and Ca salt or Na salt of aromatic sulfonic acid or saturated aliphatic dicarboxylic acid as a rust-inhibitive additive, where the thickener is in a proportion of 10-40% by weight, and the additive is in a proportion of 0.3-10% by weight, on the basis of total weight of the composition, the balance being the fluoro-oil. The lubricant composition containing the powdery fluororesin in an appropriate admixing proportion as a thickener in the fluoro oil has a distinguished rust inhibition, particularly even after having being subjected to heat hysteresis, where a perfluoropolyether oil is usually used as a fluoro-oil. | 2009-10-29 |
20090270293 | Cutting and lubricating composition for use with a wire cutting apparatus - The invention relates to a cutting and lubricating suspension composition containing gelatinous particles for cutting hard and brittle material with a wire saw. The composition contains an in situ partially neutralized polyelectrolyte and a glycol which suspends abrasive particles used in the cutting operation. | 2009-10-29 |
20090270294 | MULTIFUNCTIONAL LUBRICATING FLUID - The application pertains to multifunctional lubricating fluids for use in the different assemblies of automotive vehicles, mainly the engine, the transmission or a hydraulic circuit, and relates to a lubricant composition containing at least one oil of the groups I to V and a mixture of at least two polymers having a difference of the permanent shearing stability index (PSSI), as measured by the standardised KRL test for 20 hours at 1000° C., of at least 50, and having a viscosity profile such that: (a) at 1000° C., after a 30 cycle Bosch test following the CEC-L-14-A-93 standard, the viscosity of the final lubricant composition is higher than 9.0 cSt, preferably in range of 9.0 to 12.0 cSt for a 30 grade starting oil, or the viscosity of the final lubricant composition is higher than 12.0 cSt, preferably in range of 12.0 to 15.0 cSt for a 40 grade starting oil; (b) at 1000° C., after a 20 hour KRL test following the CEC-L-45-A-99 standard, the viscosity of the final lubricant composition is higher than 8.5 cSt, preferably in range of 8.5 to 11.0 cSt for a 30 or 40 grade starting oil; and (c) at 400° C., after a 3 hour KRL test following the CEC-L-45-A-99 standard with a test duration down to 3 hours, the viscosity of the final lubricant composition is lower than 51.0 cSt, preferably in range of 41 to 51 cSt for a 30 or 40 grade starting oil. | 2009-10-29 |
20090270295 | REFRIGERATOR OIL COMPOSITION - Provided is a refrigerating machine oil composition including a base oil which contains at least one substance selected from the group consisting of monoether compounds, alkyleneglycol diethers, and polyoxyalkyleneglycol diethers having an average repetition number of an oxyalkylene group of 2 or less as a main component, and has a kinematic viscosity at 40° C. of 1 to 8 mm | 2009-10-29 |
20090270296 | HydroxyAromatic Functionalized Polyalpha-Olefins - This invention relates to a hydroxyaromatic functionalized polyalpha-olefin comprising the product of the combination of:
| 2009-10-29 |
20090270297 | Environmentally responsible personal cleansing compositions with high performance - A method is provided for formulating a personal cleansing composition. At least one primary surfactant, at least one secondary amphoteric and/or nonionic surfactant, at least one humectant, and at least one polymeric and/or quaternary conditioner are selected, each of these components having a natural and renewable resource origin. The primary and secondary surfactants are combined with the at least one humectant and the at least one conditioner in a final composition that includes the combined primary and secondary surfactants at less than about 14 wt. %, and includes the combined at least one humectant and at least one conditioner at less than 5.5 wt. %. After forming the final composition, an optimum performance index (OPI) is determined for the composition to ensure that the composition has an OPI of at least about 5.450. The OPI is calculated as: OPI=3÷((solids wt. %+Zein score)÷performance grade). | 2009-10-29 |
20090270298 | COSMETIC COMPOSITION WITH A HEATING EFFECT - Cosmetic composition containing, in an anhydrous medium, at least one exothermic metal salt, at least one carboxylic acid and at least one salicylic acid compound, chosen from salicylic acid and salicylic acid derivatives. The composition may be used in particular for cleansing and/or removing makeup from and/or scrubbing the skin. | 2009-10-29 |
20090270299 | Composition for removing protective layer in fabrication of MEMS and method for removing same - There is provided a composition that can effectively remove a protective coating and a primer coating that have a resistance to etching solutions and are rendered unnecessary after wet-etching treatment in MEMS fabrication processes, and a method for removing the protective layer. The composition contains (A) at least one organic solvent selected from the group consisting of amides, lactones, pyrrolidones and ketones, (B) water, and (C) a fluoride, in an amount of 80.00 to 99.90 mass %, 0.05 to 12.00 mass %, and 0.05 to 8.00 mass %, respectively. The composition may further contain (D) phosphoric acid, phosphonic acid or phosphinic acid in an amount over 0 mass part to 5.5 mass parts, or (E) an organic amine in an amount over 0 mass part to 45 mass parts, based on 100 mass parts of the composition. | 2009-10-29 |
20090270300 | Composition for removing protective layer in fabrication of mems and method for removing same - There is provided a composition that can effectively remove a protective coating and a primer coating that have a resistance to etching solutions and are rendered unnecessary after wet-etching treatment in MEMS fabrication processes, and a method for removing the protective layer. The composition contains (A) at least one organic solvent selected from the group consisting of amides, lactones, pyrrolidones and ketones, (B) water, and (C) a fluoride, in an amount of 80.00 to 99.90 mass %, 0.05 to 12.00 mass %, and 0.05 to 8.00 mass %, respectively. The composition may further contain (D) phosphoric acid, phosphonic acid or phosphinic acid in an amount over 0 mass part to 5.5 mass parts, or (E) an organic amine in an amount over 0 mass part to 45 mass parts, based on 100 mass parts of the composition. | 2009-10-29 |
20090270301 | HETEROGENEOUS CLEANING COMPOSITION AND METHODS - The present invention relates to heterogeneous cleaning compositions, methods employing them, and methods of making them. | 2009-10-29 |
20090270302 | COMPOSITION FOR USE IN THE LAUNDERING OR TREATMENT OF FABRICS, AND A PROCESS FOR MAKING THE COMPOSITION - The present invention relates to an auxiliary composition, for use in the laundering or treatment of fabrics, comprising an admix of (i) clay and (ii) a silicone in an emulsified form. | 2009-10-29 |
20090270303 | Method for the Production of Particulate Bleaching Agent Compositions - The production of bleaching agent granulates, wherein a particulate peroxide compound and a water soluble polymer which can be ionotropically cross-linked are granulated into a primary granulate using a liquid binding agent containing water, and the primary granulate is brought into contact with a cross-linking agent for the water soluble polymer which can be ionotropically cross-linked. A particle so obtained can be worked into liquid detergents and cleaning agents containing water and remain stable. | 2009-10-29 |
20090270304 | LIQUID ACIDIC HARD SURFACE CLEANING COMPOSITION - The present invention relates to a liquid acidic hard surface cleaning composition comprising an acid system, wherein the acid system comprises formic acid and acetic acid. | 2009-10-29 |
20090270305 | CLEANING COMPOSITION - Multi-surface cleaning compositions and methods of use. Compositions have a combination of an alkyl polyglucoside and pyrrolidone, present in an actives ratio of at least 2:1, sometimes at least 5:1. A composition concentrate can be diluted with water, at a ratio of 1:800 or even 1:900, to form an acceptable use-composition. | 2009-10-29 |
20090270306 | Glass Storage - A stain inhibitor, which acts to neutralise alkali leached to the surface of a sheet of glass in the presence of water is disclosed. The stain inhibitor comprises a buffered, non-acidic compound, with a pKa value of between 6.0 and 10. Preferably, the non-acidic buffer compound is a mixture of boric acid and borax. | 2009-10-29 |
20090270307 | STAIN REMOVER CONTAINING FLUOROPOLYMER - A stain remover which comprises a copolymer made from as essential ingredients (a) a polymerizable monomer having a polyfluoroalkyl group with less than 8 carbon atoms and represented by the general formula H | 2009-10-29 |
20090270308 | Controlled release implantable dispensing device and method - A dispensing device having a polymer which is combined with a therapeutic agent in the form of a microparticle or nanoparticle which is “hyper-compressed” to form a controlled release dispensing device and methods of locally administering a therapeutic agent using said microparticles. | 2009-10-29 |
20090270309 | USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES - The present invention relates to use of at least one lactoferrin fragment or a lactoferrin hydrolysate or a mixture thereof for stimulating skeletal growth, inhibiting bone resorption, stimulating chondrocyte proliferation, stimulating osteoblast proliferation, inhibiting osteoclast development or treating or preventing a skeletal, joint or cartilage disorder. | 2009-10-29 |
20090270310 | Process for the preparation of a nutrient formulation - The present invention relates to a process for increasing the efficacy and/or bioavailability of a nutrient formulation or composition for the treatment and/or prevention of inflammatory processes associated with airway diseases such as asthma. In particular, the invention relates to a method of treating an airway disease in a subject in need of such treatment, comprising the step of administering a nutrient formulation or composition which comprises one or more components which have been agitated such that a harmonic of between 20 to 50 Hz has been produced, in an amount effective to treat said disease. | 2009-10-29 |
20090270311 | TREATMENT OF INSULIN RESISTANCE BY MODULATING SOMATOSTATIN USING SOMATOSTATIN RECEPTOR ANTAGONISTS - The present invention provides the use of somatostatin antagonists for treating and preventing HISS-dependent insulin resistance and hemorrhage induced insulin resistance. The present further provides pharmaceutical compositions comprising a somatostatin antagonist and a pharmaceutically acceptable liver targeting compound. | 2009-10-29 |
20090270312 | HIV-I GP41 FUSION PEPTIDES FOR IMMUNOMODULALTION - The present invention provides pharmaceutical compositions and methods for prevention or treatment of autoimmune diseases and other T cell mediated inflammatory diseases and conditions, which comprise as an active ingredient an effective quantity of a peptide derived from HIV gp41 fusion peptide domain or fragments, analogs, homologs and derivatives thereof. The invention further provides novel peptides derived from HIV gp41 fusion peptide domain, useful in the treatment of T cell mediated pathologies. | 2009-10-29 |
20090270313 | Method of Treatment for Ischemic Heart Disease - The present invention provides a method of treatment for ischemic heart disease administering a scar formation accelerator containing at least one selected from SFRP2, SFRP4, Midkine, Pleiotrophin and Thymosin beta-10 as an effective ingredient to promote scar formation less fibrosis and retaining elasticity, and thereby improving cardiac function. | 2009-10-29 |
20090270314 | POLYPEPTIDE HAVING ANTI-ANGIOGENIC ACTIVITY - The present inventors found out four kinds of fragments (42 kD, 36 kD, 32 kD, 27 kD) by forcibly expressing vasohibin in a vascular endothelial cell. The present inventors analyzed those fragments and, as a result, found out low molecular weight vasohibin which has an anti-angiogenic activity. The low molecular weight vasohibin is useful as a therapeutic agent for various diseases such as a vascular disease associated with angiogenesis, an inflammatory disease, an entoptic neovascular disease, a reproductive disease, a central nervous system disease and cancer and the like. In addition, the low molecular weight vasohibin is also useful as a marker for angiogenesis. | 2009-10-29 |
20090270315 | METHOD OF INHIBITING ANGIOGENESIS BY USING EPHRIN B2 - Methods and compositions for suppressing angiogenesis or neovascularization, as well as methods and compositions that are useful in treatment of a disease or disorder related to angiogenesis or neovascularization. | 2009-10-29 |
20090270316 | HER-2 BINDING ANTAGONISTS - There is disclosed a pharmaceutical composition for treating solid tumors that overexpress HER-2, comprising an agent selected from the group consisting of (a) an isolated polypeptide having from about 50 to 79 amino acids taken from the sequence of SEQ ID NO:1, wherein the polypeptide binds to the extracellular domain ECD of HER-2 at an affinity of at least 108, (b) an isolated and glycosylated polypeptide having from about 300 to 419 amino acids taken from the sequence of SEQ ID NO:2, wherein the C terminal 79 amino acids are present, and wherein at least three N-linked glycosylation sites are present, (c) a monoclonal antibody that binds to the ECD of HER-2, and (d) combinations thereof, with the proviso that the agent cannot be the monoclonal antibody alone, and pharmaceutically acceptable carrier. | 2009-10-29 |
20090270317 | Pharmaceutical compositions comprising bioelastomer fusion proteins - Bioelastomers are disclosed for use in methods of binding compounds including immunoassay methods, in biosensors and methods or regenerating biosensors, and in methods for targeting the delivery of a compound to a particular location within an animal subjects. In general, the bioelastomer is conjugated to a binding compound, which is in turn used to bind a compound of interest. For targeted compound delivery, the bioelastomer is conjugated to the compound to be delivered. | 2009-10-29 |
20090270318 | HIGH-AFFINITY ANTAGONISTS OF ELR-CXC CHEMOKINES - The present invention provides novel polypeptide sequences, methods for production thereof and uses thereof for novel ELR-CXC chemokine receptor agonists and antagonists. | 2009-10-29 |
20090270319 | PHARMACEUTICAL USE OF PROTEIN MOLECULES IMMUNOLOGICALLY CORRELATED TO DIPTHERIA TOXIN - Protein molecules immunologically correlated to diphtheria toxin are proposed for the treatment of atherosclerosis and further correlated pathologies. | 2009-10-29 |
20090270320 | Use of galectin-7 to promote the re-epithelialization of wounds - Methods for the therapeutic treatment of epithelial wounds in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-3 protein and/or a galectin-7 protein are provided. Pharmaceutical compositions comprising a pharmaceutically suitable carrier or diluent and as an active agent a galectin-3 protein and/or a galectin-7 protein are also provided. | 2009-10-29 |
20090270321 | Over-expression of MPS-1 gene or its gene product(s) results in reduction in size of a variety of malignancies - Metallopanstimulin-1 (MPS-1) is a multifunctional ribosomal protein. MPS-1 is a 10 kD zinc finger protein (ZFP) that is present in all tissues and expressed in increased quantities in a wide variety of proliferating tissues and malignancies. The ribosome is a ribonucleoprotein complex of ribosomal RNAs (rRNA) and proteins (r-protein). Conventionally, r-proteins are thought to be responsible for new protein synthesis, but emerging evidence has shown activity exists beyond this. Some extra-ribosomal functions of r-proteins have been observed in close relation to cancer pathology. MPS-1 is over-expressed in the serum and tissue of dozens of malignancies. However, it is unknown whether the enhanced expression of MPS-1 is the cause or result of tumor development and progression. Our preliminary observations show increased MPS-1 decreases paxillin. Recently, paxillin was found to have an important role in regulating both normal and tumor cell proliferation. | 2009-10-29 |
20090270322 | G PROTEIN COUPLED RECEPTOR ANTAGONISTS AND METHODS OF ACTIVATING AND INHIBITING G PROTEIN COUPLED RECEPTORS USING THE SAME - The invention relates generally to G protein coupled receptors and in particular to agonists and antagonists of G protein receptors and methods of using the same. | 2009-10-29 |
20090270323 | METHODS FOR TREATMENT OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY - The present invention provides methods and compositions for increasing the growth rates, alleviating the symptoms, or improving the metabolism of human patients having insulin-like growth factor-I deficiency (IGFD). The invention relates to methods comprising administering insulin-like growth factor-I to a patient having a height which, at the time of treatment or prior to initial treatment with IGF-1, is at least about 2 standard deviations below normal for a subject of the same age and gender, a blood level of insulin-like growth factor-I that, and at the time of treatment or prior to initial treatment with IGF-1, is below normal mean levels, usually at least about 1 standard deviations below normal mean levels, for age and gender. | 2009-10-29 |
20090270324 | COMPLEMENT DEPLETION USING RECOMBINANT HUMAN C-3 DERIVATIVES - The invention provides isolated polypeptides having complement-modulating activity. Specifically, the invention resides in the provision of isolated polypeptides having complement depleting properties, i.e. that effect an efficient consumption of complement in human serum. The current invention thus provides human C3 derivatives that are capable of forming C3 convertases exerting an extended CVF, Bb-like half-life of up several hours, compared to 1.5 minutes of the naturally occurring C3 convertases, thus escaping the physiological degradation mechanisms. | 2009-10-29 |
20090270325 | GROWTH FACTOR - We describe a chimeric protein comprising a growth hormone polypeptide linked to a polypeptide comprising the extracellular binding domain of growth hormone receptor; its use in enhancing the growth and metabolism of non-human animals and homodimers comprising said chimeric protein. | 2009-10-29 |
20090270326 | Cell Death Inhibitor - The present invention relates to an antioxidant response element (ARE) activator comprising a macrophage migration inhibitory factor (MIF) or a modified form thereof, an ARE activator comprising a combination of MIF or a modified form thereof and a substance capable of binding to MIF, and so on. These ARE activators are useful as safe and excellent cell death inhibitors, such as agents for the prevention/treatment of cardiovascular diseases, bone/joint diseases, infectious diseases, inflammatory diseases, renal diseases, central nervous system diseases, cancer or diabetes. | 2009-10-29 |
20090270327 | Lepidopteran-Active Bacillus Thuringiensis Delta-Endotoxin Compositions and Methods of Use - Disclosed are | 2009-10-29 |
20090270328 | METHODS OF INCREASING CEREBRAL BLOOD FLOW - Methods of increasing blood flow in a mammalian brain blood vessel characterized by, or otherwise experiencing, decreased blood flow due to an ischemic or other hypoxic event, vasoconstriction or vasospasm following hemorrhagic stroke; due to chronic high blood pressure; and/or due to idiopathic causes are provided. The method for increasing blood flow in such a mammalian brain blood vessel includes administering to a patient in need thereof a therapeutically effective amount of an inhibitor of δ protein kinase C. In certain embodiments, the inhibitor can be chronically administered without causing desensitization of the patient to the inhibitor. Kits for increasing blood flow in a mammalian brain blood vessel characterized by, or otherwise experiencing, decreased blood flow due to an ischemic or other hypoxic event, vasoconstriction or vasospasm following hemorrhagic stroke; due to chronic high blood pressure; and/or due to idiopathic causes are provided. | 2009-10-29 |
20090270329 | METHODS OF ADMINISTERING PORCINE B-DOMAINLESS FVIII - The present invention provides a method of administering porcine B-domainless factor VIII (OBI-1) to a patient having factor VIII deficiency to provide more rapid and effective protection against bleeding episodes, compared to formerly available methods, or to provide more effective protection to such patients during non-bleeding periods. This invention is based on the discovery that the recombinant B-domainless porcine fVIII, termed OBI-1, has greater bioavailability compared to the natural porcine fVIII partially purified from porcine plasma, termed HYATE:C. Therefore, the inventive method employs lower unit doses of OBI-1, including, alternatively, omission of antibody-neutralizing dosage, or has longer intervals between the administration, compared to HYATE:C, to provide equivalent protection in patients having fVIII deficiency. The invention further provides pharmaceutical compositions and kits containing OBI-1 in combination with a pharmaceutically acceptable carrier, that are useful for treating patients in need of fVIII more effectively. | 2009-10-29 |
20090270330 | PURIFIED ARABINOGALACTAN-PROTEIN (AGP) COMPOSITION USEFUL IN THE TREATMENT PSORIASIS AND OTHER DISORDERS - A purified Arabinogalactan-Protein (AGP) composition isolated through a selective method from the leaves and/or stems of | 2009-10-29 |
20090270331 | MULTI-DOMAIN AMPHIPATHIC HELICAL PEPTIDES AND METHODS OF THEIR USE - Disclosed herein are peptides or peptide analogs with multiple amphipathic α-helical domains that promote lipid efflux from cells via an ABCA1-dependent pathway. Also provided herein are methods of using multi-domain amphipathic α-helical peptides or peptide analogs to treat or inhibit dyslipidemic disorders. Methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells are also disclosed herein. | 2009-10-29 |
20090270332 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF - The present invention is based on the discovery of genetic polymorphisms that are associated with venous thrombosis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 2009-10-29 |
20090270333 | Methods of using motilin homologs - The present invention is directed to polynucleotides, polypeptides and peptide fragments thereof, and uses thereof for a novel cDNA sequence which has homology to motilin. Tissue distribution of the mRNA for the novel polypeptide is specific to the stomach, small intestine and pancreas. The present invention further includes agonists, antagonists, antibodies, host cells expressing the cDNA encoding the novel motilin homologs and methods for increasing gastric motility using the novel molecules. | 2009-10-29 |
20090270334 | NEURONAL DIFFERENTIATION INHIBITOR PEPTIDE AND USE THEREOF - Disclosed is a neuronal differentiation inhibitor which comprises at least one peptide capable of inhibiting or controlling the neuronal differentiation of at least one cell capable of being differentiated into a neuronal cell. The peptide is an artificially synthesized peptide which comprises a BC-box derived amino acid sequence comprising at least 10 contiguous amino acid residues selected from an amino acid sequence constituting the BC-box of at least one protein belonging to the elongin A family or comprises an amino acid sequence having a partial modification in the BC-box derived amino acid sequence. | 2009-10-29 |
20090270335 | COLLYRIUM FOR DRY EYE - A composition for treating dry eye includes eledoisin formulated in an ester form and a phospholipid formulated in a micellar form. | 2009-10-29 |
20090270336 | Piperazine derivatives - This invention relates to novel compounds that are piperazine derivatives, and pharmaceutically acceptable salts thereof. More specifically, the invention relates to novel piperazine compounds that are derivatives of the chemokine CCR5 receptor antagonist, vicriviroc. This invention also provides pyrogen-free compositions comprising one or more compounds of the invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are treated by administering chemokine CCR5 receptor antagonists, such as vicriviroc. The invention also relates to the use of one or more of the disclosed compounds as reagents in analytical studies involving vicriviroc. | 2009-10-29 |
20090270337 | Composition Comprising Carbohydrates and Peptides which Comprise Tryptophan - An edible composition comprising peptides rich in tryptophan, which edible composition further comprises a rapidly available glucose composition and a slowly available glucose composition. | 2009-10-29 |